Frequency of S and Z alleles for alpha-1-antitrypsin and tumor necrosis factor alpha - 308 promoter polymorphism in Northeastern Mexico

Allergy and Asthma Proceedings

Volumn 29, Issue 4, 2008, Pages 406-410

  Sánchez Domínguez, Celia Nohemí ^a,b   Buenfil Lozano, José Antonio ^a   Molina Guajardo, Carlos Alejandro ^a   Borjas Almaguer, Omar David ^a   Castillo Lartigue, Abraham ^a   Bustamante Sáenz, Adriana ^c   Martínez Rodríguez, Herminia Guadalupe ^a   Alarcón, Miguel Ángel Villarreal ^c   Reyes López, Miguel Ángel ^b   Ortiz López, Rocío ^a  

^a UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^c HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

Author keywords

AATS; AATZ; Alpha 1 antitrypsin; Cytokines; Mexican population; PCR RFLP; Polymorphisms; Population genetics; TNF 1; TNF 2; Tumor necrosis factor alpha polymorphism

Indexed keywords

EID: 50349086109     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: 10.2500/aap.2008.29.3125     Document Type: Article

References (35)

1. Shelhamer JH, Levine SJ, Wu T, et al. NIH conference. Airway inflammation. Ann Intern Med 123:288-304, 1995.
2. Davies JC, Gresenbach U, and Alton E. Modifier genes in cystic fibrosis. Pediatr Pulmonol 39:383-391, 2005.
3. Brookes AJ, Lehvaslaiho H, Siegfried M, et al. HGBASE: A database of SNPs and other variations in and around human genes. Nucleic Acids Res 28:356-360, 2000.
4. Lazarus R, Vercelli D, Palmer LJ, et al. Single nucleotide polymorphisms in innate immunity genes: Abundant variation and potential role in complex human disease. Immunol Rev 190:9-25, 2002.
5. Chappell S, Guetta-Baranés T, Batowski K, et al. Haplotypes of the alpha-1 antitrypsin gene in healthy controls and Z deficiency patients. Hum Mutat 24:535-536, 2004.
6. Sharp RR, de Serres F, Newman L, et al. Environmental, occupational, and genetic risk factors for alpha-1 antitrypsin deficiency. Environ Health Perspect 111:1749-1752, 2003.
7. Eden E, Hammel J, Rouhani FN, et al. Asthma features in severe alphal-antitrypsin deficìency: Experience of the National Heart, Lung, and Blood Institute Registry. Chest 123:765-771, 2003.
8. Piitulainen E, and Sveger T. Respiratory symptoms and lung function in young adults with severe alpha (1)-antitrypsin deficiency (PiZZ). Thorax 57:705-708, 2002.
9. Genuneit J, Weinmayr G, Radon K, et al. Smoking and the incidence of asthma during adolescence: Results of a large cohort study in Germany. Thorax 61:572-578, 2006.
10. Demeo DL, Sandhaus RA, Barker AF, et al. Determinants of airflow obstruction in severe alpha 1-antitrypsin deficiency. Thorax 62:806-813, 2007.
11. Ghafouri B, Irander K, Lindbom J, et al. Comparative proteomics of nasal fluid in seasonal allergic rhinitis. J Proteome Res 5:330-338, 2006.
12. Doring G, Krogh-Johansen H, Weidinger S, et al. Allotypes of alpha 1-antitrypsin in patients with cystic fibrosis, homozygous and heterozygous for deltaF508. Pediatr Pulmonol 18:3-7, 1994.
13. Aldallal N, McNaughto EE, Manzel LJ, et al. Inflammatory response in airway epithelial cells isolated from patients with cystic fibrosis. Am J Respir Crit Care Med 166:1248-1256, 2002.
14. Courtney JM, Ennis M, and Elborn JS. Cytokines and inflammatory mediators in cystic fibrosis. J Cyst Fibros 3:223-231, 2004.
15. Can M, Yüksel B, Demirtaçs S, et al. The effect of montelukast on soluble interleukin-2 receptor and tumor necrosis factor alpha in pediatric asthma. Allergy Asthma Proc 27:383-386, 2006.
16. Matsunaga K. The utility of exhaled breath condensate analysis for asthma management. Rinsho Byori 55:375-380, 2007.
17. Kim YJ, Lee HS, Yoon JH, et al. Association of TNF-a promoter polymorphisms with the clearance of hepatitis B virus infection. Hum Mol Genet 12:2541-2546, 2003.
18. Chen YP, Pfab T, Slowinski T, et al. Impact of genetic variation of tumor necrosis factor-alpha on gestational hypertension. Chin Med J 119:719-724, 2006.
19. Wu H, Romieu I, Sienra-Monge JJ, et al. Parental smoking modifies the relation between genetic variation in tumor necrosis factor-alpha (TNF) and childhood asthma. Environ Health Perspect 115616-622, 2007.
20. Hull J, and Thomson AH. Contribution of generic factors other than CFTR to disease severity in cystic fibrosis. Thorax 53:1018-1021, 1998.
21. Liz-Grana M, and Gomez-Reino Carnota JJ. Tumour necrosis factor. Genetics, cell action mechanism and involvement in inflammation. Allergol Immunol Clin 16:140-149, 2001.
22. Sandford AJ, Chagani T, Spinelli JJ, et al. Alphal-antitrypsin genotypes and the acute-phase response to open heart surgery. Am J Respir Crit Care Med 159:1624-1628, 1999.
23. Cerda-Flores RM, Budowle B, Jin L, et al. Maximum likelihood estimates of admixture in Northeastern Mexico using 13 short tandem repeat loci. Am J Hum Biol 14:429-439, 2002.
24. Lisker R, Perez-Briceno R, Granados J, et al. Gene frequencies and admixture estimates in a Mexico City population. Am J Phys Anthropol 71:203-207, 1986.
25. Hutchison IX. Epidemiology of alpha 1-protease inhibitor deficiency. Eur Respir J Suppl 9:29-34, 1990.
26. Colp C, Pappas J, Moran D, et al. Children with asthma Variants of alpha 1-antitrypsin in Puerto Rican. Chest 103:812-815, 1993.
27. Louis R, Leyder E, Malaise M, et al. Lack of association between adult asthma and the tumor necrosis factor alpha-308 polymorphism gene. Eur Respir J 16:604-608, 2000.
28. Vargas-Alarcón G, Casasola-Vargas J, Rodríguez-Perez JM, et al. Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with spondyloarthritis. Hum Immunol 67:826-832, 2006.
29. Rodriguez-Perez JM, Cruz-Robles D, Hernandez-Pacheco G, et al. Tumor necrosis factor-alpha promoter polymorphism in Mexican patients with Chagas' disease. Immunol Lett 98:97-102, 2005.
30. Rodriguez-Carreon AA, Zuniga J, Hernandez-Pacheco G, et al. Tumor necrosis factor-alpha -308 promoter polymorphism contributes independently to HLA alleles in the severity of rheumatoid arthritis in Mexicans. J Autoimmun 24:63-68, 2005.
31. Hernandez-Pacheco G, Flores-Dominguez C, Rodriguez-Perez JM, et al. Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with rheumatic heart disease. J Autoimmun 21:59-63, 2003.
32. Zúñiga J, Vargas-Alarcón G, Hernández-Pacheco G, et al. Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with systemic lupus erythematosus (SLE). Genes Immun 2:363-366, 2001.
33. Parra-Rojas I, Ruíz-Madrigal B, Martínez-López E, et al. Influence of the -308 TNF-alpha and -174 IL-6 polymorphisms on lipid profile in Mexican subjects. Hereditas 143:167-172, 2006.
34. Nash FT, and Florin THJ. Tumour necrosis factor inhibitors. Med J Aust 183:205-208, 2005.
35. Kim J, and Remick DG. Tumor necrosis factor inhibitors for the treatment of asthma. Curr Allergy Asthma Rep 7:151-156, 2007.